GCIA
VHAQ.RT

Gabelli & Co Investment Advisers’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio VHAQ.RT Stock Details VHAQ.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-83,100
Closed -$4.99K – 292
2023
Q4 		$4.99K Hold
83,100
– – ﹤0.01% 219
2023
Q3 		$5.04K Hold
83,100
– – ﹤0.01% 222
2023
Q2 		$4.76K Hold
83,100
– – ﹤0.01% 223
2023
Q1 		$4.16K Hold
83,100
– – ﹤0.01% 201
2022
Q4 		$10.8K Hold
83,100
– – ﹤0.01% 218
2022
Q3 		$10K Hold
83,100
– – ﹤0.01% 362
2022
Q2 		$7K Hold
83,100
– – ﹤0.01% 405
2022
Q1 		$10K Sell
83,100
-95,700
-54% -$15.3K ﹤0.01% 451
2021
Q4 		$33K Hold
178,800
– – ﹤0.01% 412
2021
Q3 		$38K Hold
178,800
– – ﹤0.01% 402
2021
Q2 		$48K Buy
+178,800
New +$36.8K 0.01% 394

Other funds holding VHAQ.RT

SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

Gabelli & Co Investment Advisers's VHAQ.RT Position: Q1 2024 in Review

Gabelli & Co Investment Advisers sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q1 2024, closing a stake of 83,100 shares — an estimated $4.99K sold.

Gabelli & Co Investment Advisers first reported a position in VHAQ.RT in Q2 2021 and held it in 11 quarters. The position peaked at $48K in Q2 2021. 5 funds tracked by Wall St. Rank hold VHAQ.RT as of Q1 2024.

  • Gabelli & Co Investment Advisers reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q1 2024 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 83,100 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q1 2024, an estimated $4.99K.
  • Gabelli & Co Investment Advisers first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q2 2021 and held it in 11 quarters.
  • Gabelli & Co Investment Advisers's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $48K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q1 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2024, filed 14 May 2024.